Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Holdings Lifted by Van Lanschot Kempen Investment Management N.V.

Van Lanschot Kempen Investment Management N.V. grew its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 461.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 563,844 shares of the real estate investment trust’s stock after purchasing an additional 463,344 shares during the period. Van Lanschot Kempen Investment Management N.V. owned approximately 0.24% of Sabra Health Care REIT worth $8,683,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Norges Bank bought a new position in Sabra Health Care REIT in the 4th quarter worth about $31,605,000. Natixis bought a new position in Sabra Health Care REIT in the 1st quarter worth about $633,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its stake in shares of Sabra Health Care REIT by 63.6% in the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 318,808 shares of the real estate investment trust’s stock worth $4,709,000 after acquiring an additional 123,966 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Sabra Health Care REIT by 2.3% in the 4th quarter. Principal Financial Group Inc. now owns 21,487,279 shares of the real estate investment trust’s stock worth $306,623,000 after acquiring an additional 484,086 shares during the period. Finally, Russell Investments Group Ltd. lifted its stake in shares of Sabra Health Care REIT by 170.2% in the 4th quarter. Russell Investments Group Ltd. now owns 399,215 shares of the real estate investment trust’s stock worth $5,697,000 after acquiring an additional 251,482 shares during the period. Institutional investors own 99.40% of the company’s stock.

Sabra Health Care REIT Price Performance

SBRA stock traded up $0.47 on Friday, hitting $16.63. 2,810,777 shares of the company’s stock traded hands, compared to its average volume of 2,046,812. Sabra Health Care REIT, Inc. has a 1-year low of $12.00 and a 1-year high of $16.94. The stock has a market cap of $3.90 billion, a price-to-earnings ratio of 83.15, a P/E/G ratio of 2.34 and a beta of 1.24. The stock has a fifty day moving average of $15.86 and a 200-day moving average of $14.72. The company has a current ratio of 4.27, a quick ratio of 4.27 and a debt-to-equity ratio of 0.89.

Sabra Health Care REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, August 7th. The real estate investment trust reported $0.10 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.24). Sabra Health Care REIT had a net margin of 7.83% and a return on equity of 1.87%. The business had revenue of $176.14 million for the quarter, compared to analyst estimates of $166.54 million. During the same period in the prior year, the company earned $0.34 earnings per share. The firm’s revenue for the quarter was up 9.3% on a year-over-year basis. On average, analysts forecast that Sabra Health Care REIT, Inc. will post 1.37 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 30th. Stockholders of record on Monday, August 19th will be issued a dividend of $0.30 per share. The ex-dividend date is Monday, August 19th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.22%. Sabra Health Care REIT’s dividend payout ratio is currently 600.00%.

Wall Street Analyst Weigh In

SBRA has been the subject of a number of research analyst reports. Scotiabank upped their price target on shares of Sabra Health Care REIT from $14.00 to $15.00 and gave the stock a “sector perform” rating in a research note on Wednesday, May 15th. Truist Financial upped their price target on shares of Sabra Health Care REIT from $15.00 to $16.00 and gave the stock a “buy” rating in a research note on Thursday, June 27th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $16.40.

Sabra Health Care REIT Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.